ICD-10 Coding for Androgenetic Alopecia(L63.9, L63.9S, L64.0)
Learn about the ICD-10 coding for androgenetic alopecia, including primary and differential codes, documentation requirements, and clinical validation.
Complete code families applicable to Androgenetic Alopecia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| L64.9 | Unspecified androgenetic alopecia | Use when androgenetic alopecia is diagnosed without specific cause or drug involvement. |
|
| L64.0 | Drug-induced androgenetic alopecia | Use when hair loss is directly linked to medication use. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAndrogenetic Alopecia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Androgenetic Alopecia.
Vague documentation of hair loss
Impact
Clinical: Misdiagnosis of alopecia type., Regulatory: Potential audit failure., Financial: Denied claims due to insufficient documentation.
Mitigation
Use specific terminology for hair loss patterns., Document all diagnostic tests and results.
Using L64.9 for drug-induced hair loss
Impact
Reimbursement: Incorrect reimbursement due to misclassification., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Use L64.0 with the appropriate drug code.
Incorrect coding of drug-induced alopecia
Impact
Failure to use L64.0 with appropriate drug code.
Mitigation
Educate coders on proper documentation and coding requirements.